PHARMAFUTURE ™ 2011 - Knowledge Conclave was held on October 1, 2011. The event was well received and attended by senior professionals from top global pharma companies.
The potential of emerging countries has been well recognized. “PHARMAFUTURE ™ 2011 - Knowledge Conclave” explored the challenges that the global pharmaceutical companies face as they rapidly scale up their operations in the emerging markets. The conclave was addressed by key industry experts. They outlined the progress made so far in emerging markets and provided an outlook towards future development and implementation of strategies.
The traditional pharmaceutical business models from mature markets have undergone considerable course-corrections over a period of time. The Panel discussion at the conclave discussed these course-corrections and how one could adapt them to the realities of the emerging markets. To explore the proceedings in more detail, please follow the link to the event coverage.
Bob Glaser, Chief Marketing & Sales Officer, Indegene
|15:30-16:15||Speaker Session 1: Bob Glaser, Chief Marketing & Sales Officer, Indegene|
|16:15-17:00||Speaker Session 2:
'The New Stakeholders - Shifting of Influence' - Bijay Singh, Sr. Vice President of Greater China Region(GCR), Head of Greater China Pharma Organization (GCPO), Guangzhou Headquarters and Hong Kong CPO, Novartis
‘Shortening the Learning Curve - Real-life Experiences’ Moderated by Bob Glaser
|18:45 onwards||Cocktails and Networking|
Sanjay started his career with Bayer in 1996 with their Pharmaceutical Division in the United States, right out of business school. He has worked in various sales and marketing positions in the US. After a stint as Executive Assistant to the President – North America, in 2000, he was transferred to the Bayer AG Headquarters in Germany, where he was part of the finance team, followed by a spell as Deputy Director with Global Strategic Marketing. In 2003, Sanjay was designated as Country Head of Bayer Healthcare in the Philippines. He was then transferred to India in 2007 as Managing Director for Bayer Pharmaceuticals Ltd. and as the Bayer Healthcare Country Representative. He is currently based in Singapore.
Sanjay studied chemical engineering and graduated with an MBA.
Bijay has held leadership roles in Marketing and Sales across Europe and Asia Pacific region. He joined Novartis in September 2004. He has led teams in Thailand, Philippines, North America, and Europe across a range of therapeutic areas in both mass market as well as specialty therapy segments.
Bijay holds a Bachelor's Degree in Business Administration from Simon Fraser University, Canada, and an MBA from Stanford University.
Bob has over 25 years of experience in the pharmaceutical and biotechnology industry. He has managed operating groups in both large and small companies, and has served as a consultant working with CEOs and the Boards of Directors on planning the strategic growth of their organizations. Earlier, he spent over 20 years with Merck & Co., Inc.
Bob started his career as a professional sales representative and after many other assignments of greater responsibilities, he became the Senior Vice President of Marketing, Human Health Group at Merck, U.S. Most notably, he was instrumental in the formation of the Merck Vaccine Division, where he was responsible for providing strategic leadership for a new group to commercialize vaccines worldwide. In his role, he was responsible for the U.S launch of several key Merck brands. He also has commercialization experience in the areas of cardiovascular, metabolic, CNS, osteoporosis, anti-inflammatory, anti-viral, ophthalmic, oncology products, and adult and pediatric vaccines.
Bob earned a Masters degree in Management from the Kellogg School of Business at Northwestern University, and a Bachelor's degree in Biology from Gettysburg College. He currently sits on the Board of Directors of ViroPharma Inc. and MicroMass Communications Inc.
Sanjiv has over 22 years of experience in Pharmaceutical industry with varied experience across business functions. He began his career with Hoechst India as a management trainee, and then moved on to look after the Exports business at Hoechst. He was later deputed to Frankfurt to work with the East Europe team to improve business processes for Russia and Ukraine.
In 1999, after his return to India, he moved into the role of project leader for Aventis formation during the merger of Hoechst Marion Roussel and RPR in India. In late 2001, he moved to Aventis Philippines as Supply Chain Head to re-engineer the supply chain function. On his return to India, he looked after the sales function, and later established the Healthcare Solutions function. In 2006, he left Sanofi-Aventis and joined Baxter India as their Business Unit Director for Renal business (South Asia).
In June 2007, he joined MSD India to head their Sales and Marketing function, and played a key role in establishing the subsidiary in India.
Sanjiv has been a speaker at several national and international seminars. He holds a Degree in Pharmacy and a Masters Degree in Business Administration..
Shrihari has rich experience in healthcare industry with diverse experience across affiliate operations, sales, marketing, and business development. He has successfully built and lead teams in chronic therapy areas like diabetes, CVS disorders, obesity, thyroid, CNS, nutrition, and nutraceuticals. He has contributed to strategic marketing services across portfolio decisions, marketing excellence, market research, and field administration..
Earlier, as Country Manager for Abbott Nutraceuticals, he played a key role in design and implementation of India entry and expansion strategy including portfolio decision, manufacturing, regulatory strategy, and commercial plans.
He has experience across both medical marketing ( HCP promotion) and direct-to-consumer marketing, and has been closely involved in channel management of pharmaceutical and FMCG products across the traditional and modern trade formats. He has led brand expansion from healthcare professional domain to consumer domain.
Mukul joined Novartis in May 2004 as the Business Head for Ophthalmics. From May 2009, he has handled additional responsibility for other therapeutic areas of Novartis such as respiratory and dermatology. He has moved to his new role as Head of Institutional business and New Audiences in February, 2011.
He is passionate about innovation in healthcare and improving patient access to quality healthcare. This new assignment enables him to strengthen Novartis' leadership on initiatives such as partnering with Healthcare Insurance and exploring other innovative models of patient accessibility to healthcare.
He previously worked at the International Marketing Division of Ranbaxy as General Manager– Business Development & Licensing. Prior to that (since June 2001), he was the Business Head at the CNS division of Ranbaxy.
He began his career with Lyka pharmaceuticals as a management trainee in June 1990. After spending a year in the field, he moved into the marketing function. Since then, he has handled various assignments with increasing responsibility in MNC & Indian Pharmaceutical companies such as Wyeth, E.Merck, and Johnson & Johnson across various therapeutic areas, ranging from mass-market products like antibiotics & vitamins to specialty segments like CNS & Oncology.
He has a keen interest in academics, and has been associated with S.I.E.S College of Management as a visiting faculty for their Pharmaceutical MBA & Biotechnology MBA programs since January 2005. He has also been on the Board of Studies for this program since 2007.
Mukul has an MBA degree from Pune University, and a Masters in Pharmacy from Goa College of Pharmacy affiliated to Bombay University.
Suresh Subramanian is currently Director of Exponentia, the largest Business Unit of Pfizer Ltd. The business has an annual turnover of around 650 crores and an employee strength close to 1400.
He has over 27 years of experience in the Pharmaceutical Industry. He has led large businesses of major Pharma companies in India and Thailand, and has a wide repertoire of experience in areas such as business leadership, strategic planning, business development, marketing & sales management, and training in companies like Astra Zeneca, Novartis, and GSK.
Suresh was part of the steering committee of the “India Pharma 2020” by Mckinsey & Company. He is a member of the OPPI adjudicating committee that monitors and oversees compliance of its members with the OPPI Code of Pharmaceutical Marketing Practices. He is also a member of the OPPI Marketing Committee.
He has been recognized in his career for leading many best practices in areas of Organizational Transformation, Field Force Excellence & Development, and DTC marketing.
Werner is a dyed-in-the-wool marketer, having extensive experience in both private and public sectors across multiple countries in the Middle East and in South Africa. He has managed brands and portfolios in numerous therapeutic areas. He has a singular passion for delivering customer centric initiatives encompassing physician education, differential diagnosis, and patient compliance. Some of these have been recognized as industry best practices. He has conceptualized and led executional teams for several innovative programs. He led an online patient compliance and patient education project for osteoporosis patients covering multiple geographies. He has also implemented a project measuring 24 hour ambulatory blood pressure, coupled to physician education nationwide to multiple specialties in South Africa.
3 Learning from the Past to Model Future Success - A View from the West Bob Glaser Chief Marketing & Sales Officer, Indegene. Watch Video
New Physician Engagement Models - Technology as an Enabler Sanjay Murudeshwar Head – Regional Operations, Asia-Pacific, Bayer Healthcare. Watch Video
The New Stakeholders - Shifting of Influence Bijay Singh Senior Vice President of Greater China Region(GCR), Novartis. Watch Video